MedTrace Logo

Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor

NCT05207852 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 288

Last updated 2022-01-26

No results posted yet for this study

Summary

This study through to the pregnant woman blood concentrations of dexamethasone therapy after research, explore the pharmacokinetic data of dexamethasone in pregnant women, Chinese pregnant women dexamethasone pharmacokinetic model, provide a reference for the clinical use of dexamethasone dose, through the biomarkers of dexamethasone to promote fetal lung maturity and other metabolomics, It provides the basis for the effectiveness and safety study of dexamethasone.

Conditions

  • Respiratory Distress Syndrome of Newborn
  • Threatened Premature Labor, Antepartum

Sponsors & Collaborators

  • Dongyang Liu

    lead OTHER

Principal Investigators

  • Liu Dongyang · Drug Clinical Trial Center

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05207852 on ClinicalTrials.gov